Product Information

CANDESARTAN CILEXETIL 16 MG TB is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.4980 per EA under NDC 62332034390. Its NADAC has been published 404 times since Feb 20, 2019.

FDA first approved this application on Dec 4, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CANDESARTAN CILEXETIL 16 MG TB

CANDESARTAN CILEXETIL
$0.4980per EA

Strength

16 mg/1

NDC

62332034390

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CANDESARTAN CILEXETIL

Approval Type

Generic (ANDA)

FDA Application

ANDA210302

FDA Approved

12/4/2018

TE Code

AB

On Market Since

12/5/2018

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for CANDESARTAN CILEXETIL 16 MG TB has been published 404 times since Feb 20, 2019, and over the history we have for it it has declined 66.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4980 per EA
All-time high$1.5048 (Mar 13, 2019)
All-time low$0.4421 (May 22, 2024)
52-week high$0.5011
52-week low$0.4745
Median price$0.7532
Average price$0.7710
Largest weekly change+37.7% (Nov 17, 2021)
Weeks tracked404
Tracking sinceFeb 20, 2019

Price History

1W

0.0%

1M

+4.1%

3M

+4.0%

6M

-0.2%

1Y

-8.3%

3Y

-28.1%

5Y

-45.8%

All

-66.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CANDESARTAN CILEXETIL 16 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN CILEXETIL 16 MG TB, manufactured by Alembic Pharmaceuticals Inc., is $0.4980 per EA (NDC 62332034390), effective Nov 11, 2026.

How has the price of CANDESARTAN CILEXETIL 16 MG TB changed over time?

Over the history we have for it, the NADAC for CANDESARTAN CILEXETIL 16 MG TB has declined 66.9%. It has been tracked across 404 weekly CMS publications since Feb 20, 2019.

What are the highest and lowest recorded NADAC prices for CANDESARTAN CILEXETIL 16 MG TB?

Since Feb 20, 2019, the NADAC for CANDESARTAN CILEXETIL 16 MG TB has ranged from a low of $0.4421 (May 22, 2024) to a high of $1.5048 (Mar 13, 2019), with a median of $0.7532 per EA.

Are there cheaper alternatives to CANDESARTAN CILEXETIL 16 MG TB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CANDESARTAN CILEXETIL 16 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures CANDESARTAN CILEXETIL 16 MG TB?

CANDESARTAN CILEXETIL 16 MG TB (NDC 62332034390) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.